$1.07 Billion is the total value of Opti Capital Management, LP's 35 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 57.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | NATERA INCnote 2.250% 5/0 | $121,729,000 | +21.8% | 40,562,000 | +23.3% | 11.42% | +6.6% | |
| Buy | DICKS SPORTING GOODS INCnote 3.250% 4/1 | $108,852,000 | +50.6% | 29,655,000 | +21.7% | 10.22% | +31.8% | |
| Buy | CONMED CORPnote 2.625% 2/0 | $70,876,000 | -0.6% | 45,565,000 | +3.4% | 6.65% | -13.0% | |
| NEW RELIC INCnote 0.500% 5/0 | $67,716,000 | +1.4% | 66,728,000 | 0.0% | 6.35% | -11.3% | ||
| Buy | ON SEMICONDUCTOR CORPnote 1.625%10/1 | $57,267,000 | +650.8% | 25,411,000 | +535.3% | 5.37% | +557.0% | |
| New | WORKIVA INCnote 1.125% 8/1 | $56,315,000 | – | 30,038,000 | +100.0% | 5.28% | – | |
| Buy | SUPERNUS PHARMACEUTICALSnote 0.625% 4/0 | $44,828,000 | +21.0% | 45,402,000 | +21.6% | 4.21% | +5.9% | |
| Buy | SAILPOINT TECHNOLOGIES HLDGSnote 0.125% 9/1 | $43,961,000 | -2.2% | 27,280,000 | +13.8% | 4.12% | -14.4% | |
| Buy | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $35,848,000 | +5.4% | 38,938,000 | +6.4% | 3.36% | -7.8% | |
| New | VEECO INSTRS INC DELnote 3.750% 6/0 | $32,937,000 | – | 18,500,000 | +100.0% | 3.09% | – | |
| COHERUS BIOSCIENCES INCnote 1.500% 4/1 | $32,235,000 | +7.6% | 29,150,000 | 0.0% | 3.02% | -5.8% | ||
| FORTIVE CORPnote 0.875% 2/1 | $32,087,000 | +0.1% | 31,927,000 | 0.0% | 3.01% | -12.4% | ||
| Sell | FIREEYE INCnote 1.625% 6/0 | $31,387,000 | -16.6% | 31,309,000 | -17.1% | 2.94% | -27.0% | |
| New | ALTERYX INCnote 0.500% 8/0 | $30,273,000 | – | 31,867,000 | +100.0% | 2.84% | – | |
| Buy | INSIGHT ENTERPRISES INCnote 0.750% 2/1 | $29,250,000 | +16.1% | 20,836,000 | +26.5% | 2.74% | +1.7% | |
| New | REPLIGEN CORPnote 0.375% 7/1 | $26,675,000 | – | 10,534,000 | +100.0% | 2.50% | – | |
| KBR INCnote 2.500%11/0 | $25,747,000 | +2.5% | 16,000,000 | 0.0% | 2.42% | -10.3% | ||
| Buy | VONAGE HLDGS CORPnote 1.750% 6/0 | $24,518,000 | +20.8% | 20,880,000 | +15.6% | 2.30% | +5.7% | |
| New | FIVE9 INCnote 0.500% 6/0 | $23,258,000 | – | 17,260,000 | +100.0% | 2.18% | – | |
| NUVASIVE INCnote 1.000% 6/0 | $22,927,000 | -2.3% | 22,410,000 | 0.0% | 2.15% | -14.5% | ||
| Sell | BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $18,030,000 | -34.7% | 17,461,000 | -34.0% | 1.69% | -42.9% | |
| Sell | MODEL N INCnote 2.625% 6/0 | $15,195,000 | -4.6% | 12,000,000 | -4.0% | 1.43% | -16.5% | |
| OMEROS CORPnote 6.250%11/1 | $14,388,000 | -2.5% | 13,200,000 | 0.0% | 1.35% | -14.7% | ||
| Buy | NATIONAL VISION HLDGS INCnote 2.500% 5/1 | $14,278,000 | +115.5% | 7,416,000 | +97.8% | 1.34% | +88.7% | |
| PEGASYSTEMS INCnote 0.750% 3/0 | $13,045,000 | -5.2% | 11,500,000 | 0.0% | 1.22% | -17.1% | ||
| FLEXION THERAPEUTICS INCnote 3.375% 5/0 | $11,742,000 | -1.8% | 13,158,000 | 0.0% | 1.10% | -14.0% | ||
| Sell | KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $11,437,000 | -23.9% | 14,960,000 | -0.3% | 1.07% | -33.4% | |
| New | RAMBUS INC DELnote 1.375% 2/0 | $8,868,000 | – | 7,000,000 | +100.0% | 0.83% | – | |
| Buy | LIGAND PHARMACEUTICALS INCnote 0.750% 5/1 | $8,782,000 | +31.5% | 8,722,000 | +29.8% | 0.82% | +15.1% | |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $8,383,000 | -4.1% | 8,000,000 | 0.0% | 0.79% | -16.0% | ||
| IRONWOOD PHARMACEUTICALS INCnote 0.750% 6/1 | $6,265,000 | +0.7% | 5,300,000 | 0.0% | 0.59% | -11.8% | ||
| New | CSG SYS INTL INCnote 4.250% 3/1 | $4,647,000 | – | 4,500,000 | +100.0% | 0.44% | – | |
| New | VIAVI SOLUTIONS INCnote 1.000% 3/0 | $4,426,000 | – | 3,388,000 | +100.0% | 0.42% | – | |
| New | LENDINGTREE INCnote 0.500% 7/1 | $4,275,000 | – | 5,000,000 | +100.0% | 0.40% | – | |
| New | FIREEYE INCnote 0.875% 6/0 | $3,199,000 | – | 3,000,000 | +100.0% | 0.30% | – | |
| PSTG | Exit | PURE STORAGE INCcl a | $0 | – | -25,000 | -100.0% | -0.05% | – |
| Exit | OMEROS CORPnote 5.250% 2/1 | $0 | – | -4,000,000 | -100.0% | -0.48% | – | |
| Exit | EVOLENT HEALTH INCnote 1.500%10/1 | $0 | – | -5,000,000 | -100.0% | -0.52% | – | |
| Exit | LUMINEX CORP DELnote 3.000% 5/1 | $0 | – | -5,806,000 | -100.0% | -0.62% | – | |
| Exit | WAYFAIR INCnote 1.125%11/0 | $0 | – | -2,500,000 | -100.0% | -0.74% | – | |
| Exit | OPKO HEALTH INCnote 4.500% 2/1 | $0 | – | -6,200,000 | -100.0% | -0.86% | – | |
| Exit | RETROPHIN INCnote 2.500% 9/1 | $0 | – | -22,582,000 | -100.0% | -2.07% | – | |
| Exit | BURLINGTON STORES INCnote 2.250% 4/1 | $0 | – | -14,500,000 | -100.0% | -2.47% | – | |
| Exit | SLACK TECHNOLOGIES INCnote 0.500% 4/1 | $0 | – | -31,315,000 | -100.0% | -5.07% | – | |
| Exit | CREE INCnote 1.750% 5/0 | $0 | – | -26,504,000 | -100.0% | -6.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SUPERNUS PHARMACEUTICALS INC | 14 | Q1 2023 | 6.9% |
| NEW RELIC INC | 14 | Q1 2023 | 7.6% |
| 8X8 INC NEW | 13 | Q3 2023 | 7.4% |
| MANDIANT INC | 12 | Q1 2022 | 9.9% |
| NUTANIX INC | 12 | Q4 2022 | 7.3% |
| OPKO HEALTH INC | 12 | Q3 2023 | 2.1% |
| INSIGHT ENTERPRISES INC | 10 | Q3 2023 | 5.6% |
| ALTERYX INC | 10 | Q3 2023 | 4.6% |
| IONIS PHARMACEUTICALS INC | 10 | Q1 2023 | 3.6% |
| MODEL N INC | 10 | Q3 2023 | 1.7% |
View Opti Capital Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Opti Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.